Bloomberg: Unilever Considers Increasing Offer For GSK Consumer Healthcare

As per a report published in Bloomberg, Unilever PLC (UN,ULVR.L,UL) has held talks with banks regarding additional financing for a new offer for GlaxoSmithKline's (GSK.L,GSK) Consumer Products division.

On Saturday, GSK stated that it rejected all three proposals from Unilever plc to acquire the GSK Consumer Healthcare business. The latest proposal was for a total acquisition value of 50 billion pounds comprising 41.7 billion pounds in cash and 8.3 billion pounds in Unilever shares.

The Consumer Healthcare business is a joint venture between GlaxoSmithKline and Pfizer, with GSK holding a majority controlling interest of 68% and Pfizer 32%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Teva Pharmaceuticals USA, Inc. has recalled one lot of platelet-reducing drug Anagrelide in the form of capsules due to dissolution test failure detected during routine stability testing, the U.S. Food and Drug Administration, or FDA, said in a statement. The U.S. Food and Drug Administration said it has taken steps to make available millions of cans of additional infant and specialty formula to U.S. consumers in the coming months. Under the agency's recent increased flexibilities, British nutrition products maker Kendal Nutricare will send about 2 million cans of infant formula under the Kendamil brand initially to U.S. beginning in June. Video streaming giant Netflix Inc. announced the availability of a variety of mobile games. Players can download the games directly from the Netflix mobile app. The new games include Dragon Up (East Side Games), Moonlighter (11 Bit Studios), Townsmen - A Kingdom Rebuilt (HandyGames), and Exploding Kittens - The Game (Exploding Kittens Digital).
Follow RTT